HIGHLIGHTS
- who: Sukumaran Anil from the Oral Health Institute, Department of Dentistry, Hamad Medical Corporation, Qatar University, Thiruvalla, Pathanamthitta, Kerala, India have published the paper: Potential Medical Applications of Chitooligosaccharides, in the Journal: Polymers 2022, 14, x FOR PEER REVIEW post-treatment of /2022/
- how: In human lung epithelial A549 cells the gallic acid-conjugated COS was tested for its antioxidant and anti-inflammatory properties.
- future: Research is required to determine the effect on more extended inflammatory periods and the bioavailability of these substances. Future investigations and translational research should investigate COS therapeutic effects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.